Polypragmasy at treatment of <i>H. pylori</i> infection in patients with concomitant diseases of other organs and systems. How to prevent side effects related to drug interactions?
The aim of the publication. Issues of drug interaction, side effects development at patients with combined diseases, requiring eradication treatment, are taken into account.Original positions. Being based on literature data and own experience, authors demonstrated, that drug interactions are observe...
Saved in:
| Main Authors: | S. G. Burkov, N. V. Shornikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2011-05-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs
by: V. T. Ivashkin, et al.
Published: (2012-11-01) -
Pantoprazole – safety in drug-drug interaction
by: E. V. Shikh, et al.
Published: (2012-09-01) -
Outpatient Management of Acute Respiratory Infections in Children
by: Radima A. Mukozheva, et al.
Published: (2021-12-01) -
Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection
by: Soo Yeon Choi, et al.
Published: (2023-06-01) -
Improving the effectiveness of H. pylori eradication therapy: focus on patient compliance and treatment safety
by: M. D. Ardatskaya, et al.
Published: (2021-06-01)